unknown
Stage
About
Gemphire Therapeutics develops treatments addressing unmet medical needs in patients with Painful Diabetic Neuropathy (PDN) and Alzheimer’s disease following a merger with NeuroBo Pharmaceuticals in 2019.
Explore Gemphire Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.